Search Results - "Heys, S"

Refine Results
  1. 1

    Chronic preoperative pain and psychological robustness predict acute postoperative pain outcomes after surgery for breast cancer by Bruce, J, Thornton, A J, Scott, N W, Marfizo, S, Powell, R, Johnston, M, Wells, M, Heys, S D, Thompson, A M

    Published in British journal of cancer (04-09-2012)
    “…Background: Few epidemiological studies have prospectively investigated preoperative and surgical risk factors for acute postoperative pain after surgery for…”
    Get full text
    Journal Article
  2. 2

    use of FDG-PET in assessing axillary lymph node status in breast cancer: a systematic review and meta-analysis of the literature by Peare, Rebecca, Staff, R. T, Heys, S. D

    Published in Breast cancer research and treatment (01-08-2010)
    “…Axillary lymph node status is the most powerful prognostic indicator in patients with breast cancer. FDG-PET has been suggested as a non-invasive method of…”
    Get full text
    Journal Article
  3. 3

    Multifocal and multicentric breast cancer, is it time to think again? by Masannat, Y A, Agrawal, A, Maraqa, L, Fuller, M, Down, S K, Tang, Ssk, Pang, D, Kontos, M, Romics, L, Heys, S D

    “…Multifocal multicentric breast cancer has traditionally been considered a contraindication to breast conserving surgery because of concerns regarding…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Complementary and alternative medicines use by Scottish women with breast cancer. What, why and the potential for drug interactions? by McLay, J. S., Stewart, D., George, J., Rore, C., Heys, S. D.

    Published in European journal of clinical pharmacology (01-05-2012)
    “…Background Despite the increased use of complementary and alternative medicine (CAM) by breast cancer patients, there is little published information regarding…”
    Get full text
    Journal Article
  6. 6

    Effect of CLA supplementation on immune function in young healthy volunteers by Song, H.J, Grant, I, Rotondo, D, Mohede, I, Sattar, N, Heys, S.D, Wahle, K.W.J

    Published in European journal of clinical nutrition (01-04-2005)
    “…Objectives: This study investigated the effect of dietary CLA supplementation (3g/day; 50:50 mix of the two major isomers) on the immune system and plasma…”
    Get full text
    Journal Article
  7. 7

    Enteral nutritional supplementation with key nutrients in patients with critical illness and cancer : A meta-analysis of randomized controlled clinical trials by HEYS, S. D, WALKER, L. G, SMITH, I, EREMIN, O

    Published in Annals of surgery (01-04-1999)
    “…To conduct a meta-analysis of 11 randomized controlled trials comparing enteral nutritional support supplemented with key nutrients versus standard enteral…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Moving inwards, moving outwards, moving upwards: the role of spirituality during the early stages of breast cancer by SWINTON, J., BAIN, V., INGRAM, S., HEYS, S.D.

    Published in European journal of cancer care (01-09-2011)
    “…SWINTON J., BAIN V., INGRAM S. & HEYS S.D. (2011) European Journal of Cancer Care20, 640–652 Moving inwards, moving outwards, moving upwards: the role of…”
    Get full text
    Journal Article
  10. 10

    Natural killer cells and cancer by Brittenden, Julie, Heys, S. D., Ross, J., Eremin, O.

    Published in Cancer (01-04-1996)
    “…BACKGROUND Natural cytotoxicity, mediated by natural killer (NK) cells and cells with lymphokine‐activated killer (LAK) activity, is believed to play an…”
    Get full text
    Journal Article
  11. 11

    Omega-3 N-acylethanolamines are endogenously synthesised from omega-3 fatty acids in different human prostate and breast cancer cell lines by Brown, I, Wahle, K.W.J, Cascio, M.G, Smoum-Jaouni, R, Mechoulam, R, Pertwee, R.G, Heys, S.D

    “…Abstract Omega-3 (n-3) fatty acids inhibit breast and prostate cancer cell growth. We previously showed that N-acylethanolamine derivatives of n-3 (n-3-NAE)…”
    Get full text
    Journal Article
  12. 12

    Positron Emission Tomography Using [18F]-Fluorodeoxy-d-Glucose to Predict the Pathologic Response of Breast Cancer to Primary Chemotherapy by SMITH, L. C, WELCH, A. E, HEYS, S. D, GILBERT, F. J, SHARP, P. F, HUTCHEON, A. W, MILLER, L. D, PAYNE, S, CHILCOTT, F, WAIKAR, S, WHITAKER, T, AH-SEE, A. K, EREMIN, O

    Published in Journal of clinical oncology (01-04-2000)
    “…To determine whether [(18)F]-fluorodeoxy-D-glucose ([(18)F]-FDG) positron emission tomography (PET) can predict the pathologic response of primary and…”
    Get full text
    Journal Article
  13. 13

    Exploring barriers and solutions in advancing cross-centre population data science by Jones, K H, Heys, S M, Daniels, H, Ford, D V

    “…It is widely acknowledged that population health and administrative data, especially when linked at the individual level, hold great value for research…”
    Get full text
    Journal Article
  14. 14

    The biological correlates of macroscopic breast tumour structure measured using fractal analysis in patients undergoing neoadjuvant chemotherapy by Di Giovanni, P., Ahearn, T. S., Semple, S. I. K., Lovell, L. M., Miller, I., Gilbert, F. J., Redpath, T. W., Heys, S. D., Staff, R. T.

    Published in Breast cancer research and treatment (01-06-2012)
    “…Breast cancers are evolving, multi-scale systems that are characterized by varied complex spatial structures. In this study, we measured the structural…”
    Get full text
    Journal Article
  15. 15

    Psychological, clinical and pathological effects of relaxation training and guided imagery during primary chemotherapy by WALKER, L. G, WALKER, M. B, OGSTON, K, HEYS, S. D, AH-SEE, A. K, MILLER, I. D, HUTCHEON, A. W, SARKAR, T. K, EREMIN, O

    Published in British Journal of Cancer (01-04-1999)
    “…The diagnosis and treatment of breast cancer are stressful, and stress may be associated with a poorer response to chemotherapy. There is a need, therefore, to…”
    Get full text
    Journal Article
  16. 16

    Folate and breast cancer: the role of polymorphisms in methylenetetrahydrofolate reductase (MTHFR) by Sharp, L, Little, J, Schofield, A.C, Pavlidou, E, Cotton, S.C, Miedzybrodzka, Z, Baird, J.O.C, Haites, N.E, Heys, S.D, Grubb, D.A

    Published in Cancer letters (08-07-2002)
    “…Evidence is growing that low folate status may be a factor in the aetiology of several cancers, including breast cancer. The methylenetetrahydrofolate…”
    Get full text
    Journal Article
  17. 17

    Regulation of fatty acid synthase (FAS) and apoptosis in estrogen-receptor positive and negative breast cancer cells by conjugated linoleic acids by Song, H.-J, Sneddon, A.A, Heys, S.D, Wahle, K.W.J

    “…Abstract Background Conjugated linoleic acids (CLAs) are natural dairy food components that exhibit a unique body of potential health benefits in animals and…”
    Get full text
    Journal Article
  18. 18

    Baseline MRI delivery characteristics predict change in invasive ductal breast carcinoma PET metabolism as a result of primary chemotherapy administration by Semple, SIK, Staff, RT, Heys, SD, Redpath, TW, Welch, AE, Ahearn, TS, Hutcheon, AW, Gilbert, FJ

    Published in Annals of oncology (01-09-2006)
    “…Background: The aim of the study was to investigate whether pre-therapy vascular delivery assessment [using dynamic contrast enhanced magnetic resonance…”
    Get full text
    Journal Article
  19. 19

    A survey to inform the design of a weight loss programme for overweight and obese women treated for breast cancer by Newlands, R., Clark, J., Craig, L. C. A., McNeill, G., Hoddinott, P., Heys, S.

    “…Among women who would have liked to do more physical activity (n=52, 40.3%) following their initial treatment, 48% would have preferred to do this in a group…”
    Get full text
    Journal Article
  20. 20

    Focus group discussions to inform the design of a weight loss programme suitable for overweight and obese women treated for breast cancer by Newlands, R., Clark, J., Craig, L. C. A., McNeill, G., Hoddinott, P., Heys, S.

    “…(ProQuest: ... denotes non-US-ASCII text omitted.) Women who are overweight or obese at the time of breast cancer diagnosis and/or who gain weight after…”
    Get full text
    Journal Article